title: Safe administration of muscle-relaxing botulismotoxin during treatment for leukemia.
authors.forename: Luca
authors.initials: L
authors.lastname: Lo Nigro
authors.forename: Francesco
authors.initials: F
authors.lastname: Costantino
authors.forename: Gino
authors.initials: G
authors.lastname: Schilirò
mesh_terms: D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D002675:Child, Preschool; D006801:Humans; D008297:Male; D009128:Muscle Spasticity / Q000150:complications / Q000188:drug therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications*
chemical_list: D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins